Lv1
10 积分 2025-08-28 加入
Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer
3个月前
已完结
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
3个月前
已完结
Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA–N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume Center
3个月前
已完结
Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial
6个月前
已完结
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy
6个月前
已完结
Efficacy and safety of induction immunotherapy plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
6个月前
已完结
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma
6个月前
已完结
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
6个月前
已完结
Short-course PD-1 blockade in locally advanced nasopharyngeal carcinoma: a phase II randomized trial protocol (Tori-013)
9个月前
已完结
Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
